baber/WOPTO huggingface dataset:
Patent NZ-564173-A (NZ)
Title: Thermoreversible immunological adjuvant emulsion
Inventor: KLUCKER MARIE-FRANCOISE
IPC: A61K9/107
Filed: 2006-07-07
Abstract: Disclosed is an oil-in-water adjuvant emulsion wherein it comprises at least:squalene, an aqueous solvent, a hydrophilic nonionic surfactant which is a polyoxyethylene alkyl ether, and a hydrophobic nonionic surfactant, in that it is thermoreversible and in that 90% of the population by volume of the oil drops has a size less than 200 nm. Also disclosed is a process for preparing an immunogenic composition, comprising at least one vaccine antigen and an oil-in-water emulsion, wherein emulsion comprises at least: squalene, a hydrophilic nonionic surfactant which is a polyoxyethylene alkyl ether, a hydrophobic nonionic surfactant, and, wherein the oil-in-water emulsion is obtained by means of a phase inversion temperature process.
Patent NZ-566756-A (NZ)
Title: Safety needle assembly with spring axis spaced from needle assembly axis
Inventor: JONES SCOTT
IPC: A61M5/00
Filed: 2006-09-22
Abstract: A needle safety device is provided having a housing, a needle assembly movably mounted within the housing and a spring for biasing the needle assembly within the housing. The needle assembly is movable along a first axis and the spring is movable along the second axis different from the first. There is also provided a lens for enhancing visualization of the flow of fluid through the needle safety device. There is further provided a safety sheath for covering a needle of the needle assembly and restraining the needle assembly against movement due to the bias of the spring.
Patent NZ-570553-A (NZ)
Title: Immunogenic peptide sequences from influenza A and B and uses thereof for vaccines
Inventor: STOLOFF GREGORY ALAN
IPC: A61K39/145
Filed: 2007-02-05
Abstract: A polypeptide of 15 to 40 amino acids that has an immunogenic sequence from DLEALMEWLKTRPILSPLTKGILGFVFTLTVP (SEQ ID NO: 1). The polypeptide can be immunogenic to a plurality of influenza strains and targets the influenza M1 protein. The polypeptide can be a part of a multi-epitope polypeptide. The polypeptide is used for vaccination against influenza A or influenza B viruses.
Patent NZ-570802-A (NZ)
Title: Prolongation of survival of an allograft by inhibiting complement activity
Inventor: ROTHER RUSSELL P
IPC: A61K39/395
Filed: 2007-03-02
Abstract: Provided is the use of a drug that inhibits complement activity, an IL-2 inhibitor and at least one other immunosuppressive drug that does not cause nephrotoxicity, in the manufacture of a medicament for prolonging survival of a kidney allograft in a mammal. The composition may include the drug LF15-0195.
Patent NZ-571183-A (NZ)
Title: Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
Inventor: MINTZ LIAT
IPC: A61K38/25
Filed: 2007-03-09
Abstract: Ghrelin splice-variant-like compounds having 95% sequence identity to SEQ ID NO:1 and having the formula as defined in claim 1 for treating or preventing cachexia, lipodystrophy an muscle wasting.
Patent NZ-576872-A (NZ)
Title: Buoyant actuator for wave power generator with variable response area
Inventor: BURNS ALAN ROBERT
IPC: E02B9/08
Filed: 2007-11-02
Abstract: 576872 A buoyant actuator (10) for a wave energy conversion system is disclosed. The buoyant actuator (10) comprises a body (21) defining a chamber (23) for accommodating matter. A hydrodynamic property of the body is selectively variable during operation of the buoyant actuator by changing the volume or shape of the body (21) to vary the response area.
Patent NZ-582759-A (NZ)
Title: A low-temperature, moving bed catalytic reactor for control of nox emissions from coal combustion
Inventor: ROGERS KEVIN J
IPC: C01B21/02
Filed: 2008-08-04
Abstract: An apparatus comprising: a combustion chamber for combustion of a fuel, which during operation generates a flue gas that may contain a quantity of NO that it is desired to remove; and a SCR reactor for reducing at least a portion of NO present in the flue gas, said SCR reactor comprising a moving-bed reactor that comprises first and second opposed boundaries spaced apart from one another to thereby define a substantially vertical catalyst-bed pathway therebetween, said first and second opposed boundaries comprising, respectively, a first louver stack and a second louver stack, each said louver stack comprising a series of vertically-spaced first or second louvers, respectively, said first and second louvers in the respective first and second louver stacks being inclined away from one another, said catalyst-bed pathway being defined between said first and second louver stacks; wherein flue gas travelling through said moving-bed reactor follows a path between the vertically-spaced first louvers, through the bed pathway, and then exiting between the vertically-spaced second louvers. The apparatus is a low-temperature, moving bed catalytic reactor which is suitable for control of NOx emissions from coal combustion.
Patent NZ-591427-A (NZ)
Title: P38 map kinase inhibitors
Inventor: ITO KAZUHIRO
IPC: A61P29/00
Filed: 2009-10-02
Abstract: Disclosed is a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, including all stereoisomers and tautomers thereof, wherein the substituents are as described within the specification. Examples of compounds of formula (I) include: 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-((2-(3-methylureido)pyridin-4-yl)methoxy)naphthalen-1-yl)urea;N-(4-((4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)methyl) pyridin-2-yl)tetrahydro-2H-pyran-4-carboxamide; and N-(4-((4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)methyl) pyridin-2-yl)-2-(methylthio)acetamide. Further disclosed is a pharmaceutical composition comprising a compound of formula (I), and the use of a compound of formula (I) in the manufacture of a medicament for treating chronic bronchitis, asthma, cystic fibrosis, and cancer, etc.
Patent NZ-592601-A (NZ)
Title: A pivoting coupling for a jockey wheel with a translating pivot lock feature
Inventor: COWIE WILLIAM
IPC: B60S9/00
Filed: 2011-05-02
Abstract: Disclosed is a coupling for attaching a support mechanism to a vehicle. The coupling includes a first member arranged for connection to the support mechanism, a second member arranged for connection to the vehicle and a connection between the first member and the second member. The connection is arranged to enable translating movement of the first member relative to the second member between an upper position and a lower position. In the upper position the first member is substantially prevented from pivoting relative to the second member and in the lower position the first member is free to pivot relative to the second member.
Patent NZ-593348-A (NZ)
Title: Fixing system and method
Inventor: RYAN BRAD STEWART
IPC: E04B1/35
Filed: 2009-12-21
Abstract: 593348 A composite tilt-up wall panel assembly (10) is disclosed. The assembly comprises a deck (12) formed from a plurality of metal sheets and a layer of hardened settable material cast on the deck. Each sheet has an intermediate section (32) and side margins that are turned out of the intermediate section to form stiffening formations (34) that extend between opposite ends of the sheets. The panel assembly (10) further comprises a peripheral edge (14) that extends around the deck (12), the deck (12) and the edge (14) form a cavity to receive the settable material. The side margins (34) of adjacent metal sheets overlap and are fixed together by nails with profiled shanks that extend through the overlapping side margins (34).
Patent NZ-598490-A (NZ)
Title: Treatment of macular degeneration
Inventor: KREMMIDIOTIS GABRIEL
IPC: A61P27/02
Filed: 2010-08-27
Abstract: NZ 598490 Disclosed is the use of an anti-angiogenic compound of formula (I) as defined in the complete specification or a pharmaceutically acceptable salt, solvate or a disodium phosphate ester prodrug thereof in the manufacture of a medicament for treating macular degeneration (MD) in a patient in need thereof.
Patent NZ-615091-A (NZ)
Title: Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
Inventor: JALAN RAJIV
IPC: A61P9/12
Filed: 2010-06-08
Abstract: Disclosed is the use of L-ornithine and at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for increasing liver perfusion in a subject with poor liver function.
Patent NZ-617591-A (NZ)
Title: Process for the production of estetrol intermediates
Inventor: PASCAL JEAN-CLAUDE
IPC: C07J75/00
Filed: 2012-06-01
Abstract: Disclosed is a process for the preparation of a compound of formula (I) comprising the steps of a) reacting a compound of formula (II) with a silylating or an acylating agent to produce compound of formula (III), wherein P1 is a protecting group selected from R2-Si-R3R4 or R1CO-, R1 is a group selected from C1-6alkyl or C3-6cycloalkyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; R2, R3 and R4 are each independently a group selected from C1-6alkyl or phenyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; b) halogenation or sulfinylation of the compound of formula (III) to produce a compound of formula (IV); wherein X is halo, or -SO-R5, and R5 is a group selected from C6-10aryl or heteroaryl, each group being optionally substituted by one or more substituents independently selected from chloro or C1-4alkyl; c) dehalogenation or desulfinylation of the compound of formula (IV) to produce compound of formula (V); and d) reacting the compound of formula (V) with a reducing agent to produce compound of formula (I).
Patent NZ-619656-A (NZ)
Title: Combinations of biological control agents and insecticides or fungicides
Inventor: BUGG KEVIN
IPC: A01P7/04
Filed: 2009-04-07
Abstract: Disclosed is a composition comprising Bacillus firmus CNCM I-1582 spore and a fungicide. Also disclosed is a composition comprising Bacillus firmus CNCM I-1582 spore, a fungicide and an insect control agent selected from the list: indoxacarb, spinosad, spinetoram, fipronil, ethiprole, sulfoxaflor, 4-{ [(6-brompyrid-3-yl)methyl](2-fluorethyl)amino} furan-2(5H)-on, 4-{ [(6-fluorpyrid-3-yl)methyl](2,2-difluorethyl)amino} furan-2(5H)-on, 4-{ [(2-chlor-1,3-thiazol-5-yl)methyl](2-fluorethyl)amino} furan-2(5H)-on, 4-{ [(6-chlorpyrid-3-yl)methyl](2-fluorethyl)amino} furan-2(5H)-on, 4-{ [(6-chlor-5-fluorpyrid-3-yl)methyl](methyl)amino} furan-2(5H)-on, 4-{ [(5,6-dichlorpyrid-3-yl)methyl](2-fluorethyl)amino} furan-2(5H)-on, 4-{ [(6-chlor-5-fluorpyrid-3-yl)methyl](cyclopropyl)amino} furan-2(5H)-on, 4-{ [(6-hlorpyrid-3-yl)methyl](cyclopropyl)amino} furan-2(5H)-on, 4-{ [(6-chlorpyrid-3-yl)methyl](methyl)amino} furan-2(5H)-on, [(6-chlorpyridin-3-yl)methyl](methyl)oxido-λ4-sulfanylidencyanamid, [1-(6-chlorpyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidencyanamid and its diastereomeres (A) and (B).
Patent NZ-627420-A (NZ)
Title: Apparatus and method of retreading tyres
Inventor: ERDMAN ALAN
IPC: B29D30/54
Filed: 2012-12-14
Abstract: The present invention relates to an apparatus (10) and a method for retreading a tyre (16) having a worn surface (12). The worn surface (12) is made of a thermoplastic elastomer. The apparatus (10) includes a heater (34) and a 3D printer (18). The heater (34) is adapted to heat up the worn surface (12) to a desired temperature. The 3D printer (18) is adapted to lay one or more layers of the thermoplastic elastomer onto the heated worn surface (12). The or each layer of thermoplastic elastomer is capable of adhering to the heated worn surface (12) or previously laid layer without requiring an adhesive medium or agent.
Patent NZ-706904-A (NZ)
Title: C-o-h compound processing for hydrogen or liquid fuel production
Inventor: WEAVER SAMUEL C
IPC: C10J3/00
Filed: 2012-09-18
Abstract: Methods and systems are disclosed for extracting hydrogen and/or liquid fuel from a compound comprising carbon, oxygen, and hydrogen (”C-O-H”). The compound may include cellulose, lignin, and/or hemicellulose, for example. The compound may include a waste stream that includes at least one C-O-H compound. Water may be combined with the C-O-H compound to produce a wet form of the C-O-H compound. The wet form of the C-O-H compound may be transferred into a reaction processing chamber. The wet form of the C-O-H compound may be heated within the reaction chamber such that elements of the C-O-H compound dissociate and react, with one reaction product comprising at least hydrogen gas and/or liquid fuel. Some embodiments may utilize non-oxidation reactions to produce the hydrogen and/or liquid fuel, such as hydrous pyrolysis reactions. The hydrogen gas and/or liquid fuel may be utilized to generate electrical power, heat, or power different types of engines.
Patent NZ-710729-A (NZ)
Title: Amatoxin derivatives
Inventor: ANDERL JAN
IPC: C07K7/64
Filed: 2014-03-10
Abstract: The present invention provides amatoxin derivatives of formula I, which are useful in the treatment of cancer and other disorders and diseases. The amatoxin may be conjugated via a linker and chemical moiety to a targeting moiety. In a further aspect the invention relates to pharmaceutical compositions comprising such derivatives.
Patent NZ-712659-A (NZ)
Title: SALT FORMS OF (S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
Inventor: SIEGEL CRAIG
IPC: A61P35/00
Filed: 2014-03-14
Abstract: The present invention relates to novel salt forms of (S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate useful as an inhibitor of glucosylceramide synthase (GCS) and for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
Patent NZ-716848-A (NZ)
Title: Improvements in Animal Feeders
Inventor: ROBERT DYMOCK MCINTYRE
IPC: A01K5/00
Filed: 2014-11-24
Abstract: An animal feeder F which includes a tank T and at least one manifold M adapted for the mounting of a plurality of animal feeding teats P whereby liquid feed in the tank T can flow under gravity to the manifold(s) M, the feeder F being characterized in that it includes a pressure regulating device 10 located between the tank T and the manifold(s) M. The inventive concept being a valve to control the level of liquid feed in the at least one container that regulates the level of liquid feed inside the at least one container such that the volume of liquid feed inside the at least one container is limited to a level by the valve such that the head pressure of liquid feed flowing out of the outlet is limited to the pressure established by the head pressure of liquid feed within the at least one container. This animal feeder avoids the need for user involvement altogether allowing the user to tend other activities and has the added benefit of reducing the pressure at the outlet, thus mitigating the possibility of any leaks.
Patent NZ-720190-A (NZ)
Title: System and methods for encrypting data
Inventor: GILBERT VINCENT LOGAN
IPC: H04L9/00
Filed: 2014-04-18
Abstract: A system and associated methods for encrypting data are disclosed. In at least on embodiment, a key manager is located in memory on an at least one computing device and configured for creating and managing an at least on encryption key to be used for encrypting the data. An at least on key file is also located in memory on the at least one computing device and is associated with an at least one authorized user. The key file contains a key field comprising a pseudo random string of bytes and a unique hash value used to associate the key file to the user. A set of base characters are randomly selected from the key field. An encryption key is generated by inputting the base characters into an encryption algorithm. The data is encrypted using the encryption key.
Patent NZ-731787-A (NZ)
Title: Adjustable clamping system for a sewing machine
Inventor: COOMBES REX IAN
IPC: D05C9/04
Filed: 2015-11-11
Abstract: The present disclosure generally relates to a clamping system. Particularly, the present disclosure relates to a clamping system for holding material to be sewn / embroidered by a sewing machine. The invention aims to improve the efficiency of clamping systems in sewing machines.
Patent NZ-732527-A (NZ)
Title: Pyridazinone macrocycles as irak inhibitors and uses thereof
Inventor: LAN RUOXI
IPC: A61P35/00
Filed: 2016-02-05
Abstract: The present invention relates to compounds of Formula (I) and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors. Ring A is a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; which is optionally substituted.
Patent NZ-734948-A (NZ)
Title: Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses thereof
Inventor: CADY SUSAN
IPC: A61P33/14
Filed: 2016-02-26
Abstract: This invention relates to long-acting injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a poloxamer, and a co-solvent. This invention also provides for improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the long-acting injectable formulations of the invention to the animal in need thereof.
Patent NZ-736241-A (NZ)
Title: Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy
Inventor: VASSEUR-DEMARCY BÉRANGÈRE
IPC: A61P1/08
Filed: 2015-04-17
Abstract: The present invention pertains to specific clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. It also pertains to the use of this clonidine and/or clonidine derivative for the manufacture of a pharmaceutical composition intended to prevent and/or alleviate the adverse side effects of alkylating agent chemotherapy, other than those resulting from mucosal inflammation. This invention is further directed to a kit comprising: (a) a clonidine and/or clonidine derivative, and (b) at least one alkylating chemotherapeutic agent, as a combined preparation for simultaneous, separate or sequential use in the treatment of cancer. In one embodiment the side effects treated are asthenia and fatigue.
Patent NZ-747932-A (NZ)
Title: Synthesis of 6-aryl-4-aminopicolinates and 2-aryl-6-aminopyrimidine-4-carboxylates by direct suzuki coupling
Inventor: FISK JASON S
IPC: C07D213/803
Filed: 2017-05-19
Abstract: Improved methods of synthesizing 6-aryl-4-aminopicolinates, such as arylalky and alkyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylates and arylalkyl and alkyl 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2- carboxylates, are described herein. The improved methods include a direct Suzuki coupling step, which eliminates the protection/de-protection steps in the current chemical process, and therefore eliminates or reduces various raw materials, equipment and cycle time as well as modification of other process conditions including use of crude AP, use of ABA-diMe, and varying pH, catalyst concentration, solvent composition, and/or workup procedures. This invention was expanded to include synthesis of 2-aryl-6-aminopyrimidine-4-carboxylates.
Patent NZ-760341-A (NZ)
Title: Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
Inventor: MEKONNEN BELEW
IPC: C07D237/26
Filed: 2014-12-19
Abstract: This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with central nervous system (CNS) disorders. In particular, it relates to the use of a α5-containing GABAA receptor agonist (e.g., a α5-containing GABAA receptor positive allosteric modulator) as described herein in treating cognitive impairment associated with central nervous system (CNS) disorders in a subject in need or at risk thereof, including, without limitation, subjects having or at risk for age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI (aMCI), Age-Associated Memory Impairment (AAMI), Age Related Cognitive Decline (ARCD), dementia, Alzheimer’s Disease (AD), prodromal AD, post traumatic stress disorder (PTSD), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (ALS), cancer-therapy-related cognitive impairment, mental retardation, Parkinson’s disease (PD), autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction.
Patent PT-100936-A (PT)
IPC: A61K8/9789
Filed: 1992-10-07
Abstract: In a composition for enhancing the growth of hair comprising a conditioner having the following ingredients based on a total of 500 grams by weight: water, approximately 435.5 gm; cetyl alcohol, approximately 12.5 gm; standamul 100ZK, approximately 12.5 gm; proteins, approximately 35.0 gm; citric acid, approximately 2.5 gm; honey, approximately 0.5 gm; wheat germ oil, approximately 0.5 gm; lecithin, approximately 0.5 gm; herbal extract, approximately 0.5 gm; methylchloroisothiazolinone, approximately 0.5 gm. The composition also includes a shampoo and a cleansing solution.
Patent PT-103901-A (PT)
Title: Processo catalítico para hidrogenação assimétrica.
Inventor: ALEXANDER DAVID
IPC: C07B35/02
Filed: 2007-12-12
Abstract: PROCESSO PARA PREPARAÇÃO DO ENANTIÓMERO R OU S DE UM COMPOSTO DE FÓRMULA A, PROCESSO QUE COMPREENDE A SUJEIÇÃO DE UM COMPOSTO DE FÓRMULA B A HIDROGENAÇÃO ASSIMÉTRICA NA PRESENÇA DE UM CATALISADOR QUIRAL E UMA FONTE DE HIDROGÉNIO, EM QUE: X É CH2, OXIGÉNIO OU ENXOFRE; R1, R2 E R3 SÃO IGUAIS OU DIFERENTES E SIGNIFICAM GRUPOS HIDROGÉNIO, HALOGÉNEO, ALQUILO, ALQUILOXI, HIDROXI, NITRO, ALQUILCARBONILAMINO, ALQUILAMINO OU DIALQUILAMINO; E R4 É ALQUILO OU ARILO, EM QUE: O TERMO ALQUILO SIGNIFICA CADEIA DE HIDROCARBONETO, LINEAR OU RAMIFICADA, CONTENDO UM A SEIS ÁTOMOS DE CARBONO, OPCIONALMENTE SUBSTITUÍDA POR GRUPOS ARILO, ALCOXI, HALOGÉNEO, ALCOXICARBONILO OU HIDROXICARBONILO; O TERMO ARILO SIGNIFICA UM GRUPO FENILO OU NAFTILO, OPCIONALMENTE SUBSTITUÍDO POR UM GRUPO ALQUILOXI, HALOGÉNEO OU NITRO; E O TERMO HALOGÉNEO SIGNIFICA FLÚOR, CLORO, BROMO OU IODO.
Patent PT-117440-A (PT)
Title: Processo para a preparação de aminas cíclicas cloroaquilo substituídas
Inventor: MARIANNA KATZ
IPC: C07D267/00
Filed: 2021-09-03
Abstract: A PRESENTE INVENÇÃO ESTÁ RELACIONADA EM GERAL COM UM PROCESSO PARA A PREPARAÇÃO DE AMINAS CÍCLICAS SUBSTITUÍDAS COM DERIVADOS CLOROAQUILO, ESPECIALMENTE, MAS NÃO EXCLUSIVAMENTE, AMINAS CÍCLICAS COM SUBSTITUINTES 1-(2-CLORETILO) E 1-(3-CLOROPROPILO), E EM PARTICULAR, ONDE A AMINA CÍCLICA É PIPERIDINA, OU PIPERAZINA, OU MORFOLINA, OU PIRROLIDINA OU HEXAMETILENOIMINA. EM PARTICULAR, O PROCESSO COMPREENDE FAZER REAGIR UMA AMINA CÍCLICA SECUNDÁRIA COM UM AGENTE ALQUILANTE BIFUNCIONAL, NA PRESENÇA DE UMA BASE ORGÂNICA, EM MODO DE PROCESSO POR LOTES OU EM MODO DE PROCESSO CONTÍNUO, NA AUSÊNCIA DE SOLVENTE, PARA FORMAR A RESPETIVA AMINA CÍCLICA CLOROAQUILADA.
Patent RU-94009799-A (RU)
Inventor: IPAT EV V A
IPC: A01B79/02
Filed: 1994-03-22
Abstract: FIELD: forest planting on soils contaminated with radioactive nuclides. SUBSTANCE: method involves planting woody plant and, among them, bush such as buckthorn, which may serve as antagonist, with respect to main wood stratum, in consumption of nutritive and radioactive substances. EFFECT: increased efficiency, simplified method and reduced content of radioactive nuclides in biomass.